Axsome Therapeutics Inc (AXSM)

[georgejjl]

$78 BILLION$

What is the commercial opportunity for AXS-07? Axsome estimates that there are more than 37 million people in the U.S. who suffer from migraines, and the annual direct and indirect costs of these in the U.S. amount to $78 billion. Further, more than 70% of people within this patient population are not fully satisfied with current treatments, and about 80% of them would try a new medicine.

Good luck and GOD bless,